Hong Kong at a glance
- Population
- 7.5 million 2025
- Life expectancy at birth
- 85.4 years, 2024
- People aged 65 and over
- 23.7 % of people, 2025
Updated
Reviewed by Vidhi Upadhyay
Hong Kong Heart Failure Devices Market Industry Trends and Forecast to 2034: Segmented by (Device, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$22.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $18.8 Mn | — | — |
| 2025 (base) | $20.4 Mn | +$1.6 Mn | — |
| 2026 (forecast) | $22.2 Mn | +$1.8 Mn | +8.6% |
| 2027 (forecast) | $24.1 Mn | +$1.9 Mn | +17.9% |
| 2028 (forecast) | $26.1 Mn | +$2.1 Mn | +28.1% |
| 2029 (forecast) | $28.4 Mn | +$2.2 Mn | +39.1% |
| 2030 (forecast) | $30.8 Mn | +$2.4 Mn | +51.1% |
| 2031 (forecast) | $33.5 Mn | +$2.7 Mn | +64.1% |
| 2032 (forecast) | $36.4 Mn | +$2.9 Mn | +78.2% |
| 2033 (forecast) | $39.5 Mn | +$3.1 Mn | +93.5% |
| 2034 (forecast) | $42.9 Mn | +$3.4 Mn | +110.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $20.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $42.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Device, use and end user (see all) |
| Key players | Abbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson), Impulse Dynamics (see all) |
| Regulator in Hong Kong | MDACSSource: Medical Device Division, Department of Health. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Heart failure devices help weak hearts pump or keep rhythm, including pumps, defibrillators, resynchronisation devices and sensors.
Key segments of the heart Failure Devices market include device (Ventricular Assist Devices, CRT Devices and ICDs) and use (Bridge to Transplant, Destination Therapy and Monitoring).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the heart Failure Devices market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the heart Failure Devices market.
The heart Failure Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Hong Kong has a voluntary listing system for medical devices (MDACS), run by the Medical Device Division of the Department of Health.[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.[2]
[1] Medical Device Division, Department of Health. Checked 14 Nov 2026.
[2] Hospital Authority. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how heart Failure Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Hong Kong.
What doctors and scientists are doing in Heart Failure Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
Hong Kong · 1 shared keyword
Hong Kong · 1 shared keyword
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Digital Health · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong
Healthcare Services · Hong Kong